Cokey Nguyen
President & Chief Executive Officer Atara Biotherapeutics Inc.
Seminars
Monday 7th December 2026
Implementing Commercial GMP Compliance Frameworks to Strengthen Donor-Derived Cell Therapy Manufacturing Readiness
11:00 am
- Establishing donor qualification and documentation workflows to meeting commercial GMP requirements while reducing regulatory compliance risks
- Implementing chain of identity and custody controls to strengthening donor material traceability across manufacturing operations
- Aligning quality, manufacturing and regulatory oversight to maintaining inspection readiness throughout commercial scale-up activities
